other panel (agena bioscience)
agena bioscience is a verified supplier 
agena bioscience manufactures this product 
97
Structured Review
agena bioscience
other panel
Other Panel, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 120 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+iplex+software/Other+Panel/custom%4010298%4040567296
Average 97 stars, based on 120 article reviews
Other Panel, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 120 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+iplex+software/Other+Panel/custom%4010298%4040567296
Average 97 stars, based on 120 article reviews
other panel - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Quantitative RT-PCR:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Multiplex Assay:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Reverse Transcription Polymerase Chain Reaction:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Sequencing:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Control:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Multiplexing:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Purification:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Software:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Mass Spectrometry:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Amplicon Sequencing:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Amplification:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and Diagnostic Assay:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and High Throughput Screening Assay:Article Title: Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study Article Snippet: holinergic burden deriving from non-CYP2D6-metabolised drugs was evaluated (ABS other ). Genotyping data were obtained from a previous study using the iPLEX PGx 74 and |